A systematic scoping review of the neurological effects of COVID-19.

Autor: Hogberg HT; National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, USA; Evidence-Based Toxicology Collaboration (EBTC), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Tsaioun K; Evidence-Based Toxicology Collaboration (EBTC), Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Breidenbach JD; Biochemistry and Biotechnology Group, Bioscience Division, Los Alamos National Laboratory, Los Alamos, NM 87545, USA., Elmore B; Sciome LLC, Research Triangle Park, NC, USA., Filipovska J; Independent Scientist, Ohrid, North Macedonia., Garcia-Reyero N; Office of the Secretary of Defense Energy, Installations & Environment, Washington, DC, USA., Hargreaves AJ; Nottingham Trent University, Nottingham, NG11 8NS, UK., Joshi O; University of Mumbai, Mumbai, India., Omeragic E; University of Sarajevo-Faculty of Pharmacy, Sarajevo, Bosnia and Herzegovina., Plant S; University of Sussex, UK., Ram R; Safer Medicines Trust, UK., Virmani I; Centre for Alternatives to Animal Testing, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA; RECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic., Waspe J; Sheffield Teaching Hospitals, UK., Macmillan DS; Humane Society International, 1255 23rd St. NW, Suite 450, Washington, DC 20037, USA. Electronic address: dmacmillan@hsi.org.

Publikováno v: Neurotoxicology [Neurotoxicology] 2024 Jul; Vol. 103, pp. 16-26. Date of Electronic Publication: 2024 May 18.

Use of Lhasa Limited Products for the In Silico Prediction of Drug Toxicity.

Autor: Ponting DJ; Lhasa Limited, Leeds, UK. david.ponting@lhasalimited.org., Burns MJ; Lhasa Limited, Leeds, UK., Foster RS; Lhasa Limited, Leeds, UK., Hemingway R; Lhasa Limited, Leeds, UK., Kocks G; Lhasa Limited, Leeds, UK., MacMillan DS; Lhasa Limited, Leeds, UK., Shannon-Little AL; Lhasa Limited, Leeds, UK., Tennant RE; Lhasa Limited, Leeds, UK., Tidmarsh JR; Lhasa Limited, Leeds, UK., Yeo DJ; Lhasa Limited, Leeds, UK.

Publikováno v: Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2022; Vol. 2425, pp. 435-478.

REACHing for solutions: Essential revisions to the EU chemicals regulation to modernise safety assessment.

Autor: Pereira M; Humane Society International/Europe, Research & Toxicology, Av. des Arts 50, 1000, Brussels, Belgium., Macmillan DS; Humane Society International/Europe, Research & Toxicology, Av. des Arts 50, 1000, Brussels, Belgium. Electronic address: dmacmillan@hsi.org., Willett C; Humane Society International/Europe, Research & Toxicology, Av. des Arts 50, 1000, Brussels, Belgium., Seidle T; Humane Society International/Europe, Research & Toxicology, Av. des Arts 50, 1000, Brussels, Belgium.

Publikováno v: Regulatory toxicology and pharmacology : RTP [Regul Toxicol Pharmacol] 2022 Dec; Vol. 136, pp. 105278. Date of Electronic Publication: 2022 Oct 21.

Selective Anti-Leishmanial Strathclyde Minor Groove Binders Using an N-Oxide Tail-Group Modification.

Autor: Perieteanu MC; Department of Pure and Applied Chemistry, University of Strathclyde, Glasgow G1 1XL, UK., McGee LMC; Department of Pure and Applied Chemistry, University of Strathclyde, Glasgow G1 1XL, UK., Shaw CD; Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK., MacMillan DS; Department of Pure and Applied Chemistry, University of Strathclyde, Glasgow G1 1XL, UK., Khalaf AI; Department of Pure and Applied Chemistry, University of Strathclyde, Glasgow G1 1XL, UK., Gillingwater K; Parasite Chemotherapy, Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, 4051 Basel, Switzerland.; University of Basel, 4001 Basel, Switzerland., Beveridge R; Department of Pure and Applied Chemistry, University of Strathclyde, Glasgow G1 1XL, UK., Carter KC; Strathclyde Institute of Pharmacy & Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK., Suckling CJ; Department of Pure and Applied Chemistry, University of Strathclyde, Glasgow G1 1XL, UK., Scott FJ; Department of Pure and Applied Chemistry, University of Strathclyde, Glasgow G1 1XL, UK.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2022 Oct 07; Vol. 23 (19). Date of Electronic Publication: 2022 Oct 07.

COVID-19 through Adverse Outcome Pathways: Building networks to better understand the disease - 3rd CIAO AOP Design Workshop.

Autor: Clerbaux LA; European Commission, Joint Research Centre, Ispra, Italy., Amigó N; Biosfer Teslab, Reus, Spain., Amorim MJ; Instituto Gulbenkian de Ciência, Lisbon, Portugal., Bal-Price A; European Commission, Joint Research Centre, Ispra, Italy., Batista Leite S; European Commission, Joint Research Centre, Ispra, Italy., Beronius A; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden., Bezemer GFG; Impact Station, Hilversum, The Netherlands., Bostroem AC; European Commission, Joint Research Centre, Ispra, Italy., Carusi A; Interchange Research, London, UK., Coecke S; European Commission, Joint Research Centre, Ispra, Italy., Concha R; Fairleigh Dickinson University, Green Neuroscience Laboratory, San Diego, CA, USA, Daskalopoulos EP; European Commission, Joint Research Centre, Ispra, Italy., De Bernardi F; Division of Otorhinolaryngology, Department of Biotechnologies and Life Sciences, University of Insubria, Ospedale di Circolo e Fondazione Macchi, Varese, Italy., Edrosa E; Green Neuroscience Laboratory, Neurolinx Research Institute, San Diego, CA, USA, Edwards SW; RTI International, Research Triangle Park, NC, USA., Filipovska J; Independent scientist, Ohrid, North Macedonia., Garcia-Reyero N; US Army Engineer Research and Development Center, Vicksburg, MS, USA., Gavins FNE; The Centre for Inflammation Research and Translational Medicine (CIRTM), Brunel University London, London, UK., Halappanavar S; Environmental Health Science and Research Bureau, Health Canada, Ottawa, Ontario, Canada., Hargreaves AJ; School of Science and Technology, Nottingham Trent University, Nottingham, UK., Hogberg HT; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Huynh MT; Department of Preventive Medicine and Biometrics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA., Jacobson D; Biosciences, Oak Ridge National Laboratory, Oak Ridge, TN, USA., Josephs-Spaulding J; Institute for Experimental Medicine, Kiel University, Kiel, Germany., Kim YJ; Korea Institute of Science and Technology Europe Forschungsgesellschaft mbH, Saarbrücken, Germany., Kong HJ; University of Illinois at Urbana-Champaign, Champaign, IL, USA., Krebs CE; Physicians Committee for Responsible Medicine, Washington, DC, USA., Lam A; Green Neuroscience Laboratory, Neurolinx Research Institute, San Diego, CA, USA, Landesmann B; European Commission, Joint Research Centre, Ispra, Italy., Layton A; US Consumer Product Safety Commission, Bethesda, MD, USA., Lee YO; Korea Institute of Science and Technology Europe Forschungsgesellschaft mbH, Saarbrücken, Germany., Macmillan DS; Humane Society International, Washington, DC, USA., Mantovani A; Istituto Superiore di Sanità, Rome, Italy., Margiotta-Casaluci L; The Centre for Inflammation Research and Translational Medicine (CIRTM), Brunel University London, London, UK., Martens M; Department of Bioinformatics - BiGCaT, NUTRIM, Maastricht University, Maastricht, The Netherlands., Masereeuw R; Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Mayasich SA; University of Wisconsin-Madison Aquatic Sciences Center at US EPA, Duluth, MN, USA., Mei LM; US EPA, Durham, NC, USA., Mortensen H; US EPA, Durham, NC, USA., Munoz Pineiro A; European Commission, Joint Research Centre, Geel, Belgium., Nymark P; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden., Ohayon E; Green Neuroscience Laboratory, Neurolinx Research Institute, San Diego, CA, USA, Ojasi J; Hiranandani College of Pharmacy, Mumbai, India., Paini A; European Commission, Joint Research Centre, Ispra, Italy., Parissis N; European Commission, Joint Research Centre, Ispra, Italy., Parvatam S; Centre for Predictive Human Model Systems Atal Incubation Centre - Centre for Cellular and Molecular Biology Habsiguda, Hyderabad, India., Pistollato F; European Commission, Joint Research Centre, Ispra, Italy. Francesca.PISTOLLATO@ec.europa.eu., Sachana M; Environment Health and Safety Division, Environment Directorate, Organisation for Economic Cooperation and Development (OECD), Paris, France., Sørli JB; The National Research Centre for the Working Environment, Copenhagen, Denmark., Sullivan KM; Physicians Committee for Responsible Medicine, Washington, DC, USA., Sund J; European Commission, Joint Research Centre, Ispra, Italy., Tanabe S; Division of Risk Assessment, Center for Biological Safety and Research, National Institute of Health Sciences, Kawasaki, Japan., Tsaioun K; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Vinken M; Department of Pharmaceutical and Pharmacological Sciences, Vrije Universiteit Brussel, Brussels, Belgium., Viviani L; Humane Society International, Washington, DC, USA., Waspe J; Sheffield Teaching Hospitals, Sheffield, UK., Willett C; Humane Society International, Washington, DC, USA., Wittwehr C; European Commission, Joint Research Centre, Ispra, Italy.

Publikováno v: ALTEX [ALTEX] 2022; Vol. 39 (2), pp. 322–335. Date of Electronic Publication: 2022 Jan 03.